Health care personnel should immediately notify both infection control personnel at their health care facility and their local or state health department in the event of a PUI.
Interim Criteria to Guide Testing of Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19) (DSHS)
Phone Advice Line Tool for Possible COVID-19 Patients (CDC)
DSHS COVID-19 Testing Algorithm (DSHS)
Evaluating and Reporting PUI Guidance (CDC)
Information for Health Departments on Reporting a PUI or Presumptive Positive and Laboratory-Confirmed Cases of COVID-19
Stigma Related to COVID-19 (Share Facts, Not Fear) (CDC)
Interim Guidance for Public Health Personnel Evaluating Persons Under Investigation (PUIs) and Asymptomatic Close Contacts of Confirmed Cases at Their Home or Non-Home Residential Settings (CDC)
Health Care Professional Preparedness Checklist For Transport and Arrival of Patients With Confirmed or Possible COVID-19 (CDC)
Top of page
COVID-19 is a notifiable condition that should be reported to your local health department immediately if either suspected or confirmed. Testing and specimen submission to the DSHS laboratory requires pre-approval from your local health authority. Commercial and drive through laboratory testing is also available. Please consider these as testing options for yourself and your patients due to their larger capacity to test compared to public health laboratories.
How to Obtain a Nasopharyngeal Swab Specimen (NEJM) under Specimen Collection and Testing
COVID-19 Antibody Testing Primer (IDSA)
Emergency Use Authorization (FDA)
PCR vs. Serology Testing, Explained (DSHS)
FAQs on COVID-19 Testing at Laboratories (CDC)
FAQs on Diagnostic Testing for SARS-CoV-2 (FDA)
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19) (CDC)
COVID-19 Texas Laboratory Testing Requirements (Information collected by Texas Medical Association)
New CPT code for COVID-19 testing: What you should know (AMA)
Laboratory Testing Fact Sheet for Health Care Professionals (FDA)
Laboratory Testing Fact Sheet for Patients (CDC)
COVID-19 Specimen Collection and Submission Instructions (DSHS)
FAQs for Diagnostic Tools and Virus (CDC)
Clinical Care COVID-19 Resources
Infection Control and Personal Protective Equipment (PPE) COVID-19 Resources
Specialty Physicians COVID-19 Resources
Practice Help COVID-19 Resources
COVID-19 Resources main page
November 13, 2020
What could a TMA Membership mean for you, your practice, and your patients?
Coronavirus
Physicians and health facilities should temporarily halt administering the Johnson & Johnson/Janssen COVID-19 vaccine following reports of blood clots in six people six to 13 days after receiving the vaccine. Read More
View COVID-19 resources related to practice operations. Read More
Get COVID-19 resources related to compliance. Read More
More Related Stories
Public health issues in Texas
With the 2021 Texas Legislature well under way, graduate medical education, scope of practice, and liability remain top priorities for medicine. TMA fights state budget cuts to preserve Texas’ steady progress in building residency positions. A court decision is the latest of many scope tests in the legislature and the law. And TMA seeks liability legislation to protect physicians on the front lines of a disaster. Plus ... Read about how prevention has become a more prevalent approach to addressing child abuse and neglect. And ransomware is a bigger threat than ever, but prevention is the best medicine.
Read the Latest Issue